|
| Status |
Public on Oct 01, 2022 |
| Title |
Targeting MLL methyltransferases enhance the anti-tumor effects of PI3K inhibition in hormone receptor-positive breast cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Sep 28, 2022 |
| Last update date |
Oct 03, 2022 |
| Contact name |
Jennifer Marie Spangle |
| E-mail(s) |
jennifer.spangle@emory.edu
|
| Organization name |
Emory University
|
| Street address |
1365C Clifton Rd NE
|
| City |
Atlanta |
| State/province |
Georgia |
| ZIP/Postal code |
30311 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (12)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE214329 |
Targeting MLL methyltransferases enhance the anti-tumor effects of PI3K inhibition in hormone receptor-positive breast cancer [Cut & Run] |
| GSE214331 |
Targeting MLL methyltransferases enhance the anti-tumor effects of PI3K inhibition in hormone receptor-positive breast cancer [RNA-Seq] |
|
| Relations |
| BioProject |
PRJNA885006 |
Less...
More...